| CRISPR THERAPEUTICS |
| Schweiz |
| Gesundheit |
| CH0334081137 / A2AT0Z |
| 1CG (Frankfurt) / CRSP (NASDAQ) |
| FRA:1CG, ETR:1CG, 1CG:GR, NASDAQ:CRSP |
| - |
| https://crisprtx.com/ |
|
CRISPR Therapeutics AG is a biopharmaceutical company specializing in gene editing therapies using its proprietary CRISPR/Cas9 platform. This revolutionary technology enables precise alteration of genomic DNA sequences to develop transformative medic..
>Volltext.. |
| 4537.45 Mio. EUR |
| 3029.6 Mio. EUR |
| 2.99 Mio. EUR |
| -468.3 Mio. EUR |
| -496.18 Mio. EUR |
| -5.56 EUR |
| 176.38 Mio. EUR |
| 303.02 Mio. EUR |
| -294.34 Mio. EUR |
| 13.3 |
| -91.71% |
| -39.97% |
| - |
| - |
| - |
| - |
| CRISPR THERAPEUTICS |
| 26.04.26 |
|